glp 1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Can GLP-1 agonists treat cardiovascular
Description
No subgroup or meta-regression analyses were performed owing to the small number of eligible studies
![glp 1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Can GLP-1 agonists treat cardiovascular](https://www.labiotech.eu/wp-content/uploads/2023/12/GLP-1-agonists-for-heart-diseases.jpg)
Stay there for 812 weeks
![glp 1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Can GLP-1 agonists treat cardiovascular](https://www.richardlipmanmd.com/wp-content/uploads/2025/12/BENEFITSofglp1dec162025.psdTAKE2.jpg)
In vitro experiments found compound 31 (Figure 5) to be the most potent, as predicted by in-silico simulations, with an IC 50 of 3.16 M
![glp 1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Can GLP-1 agonists treat cardiovascular](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-024-02319-7/MediaObjects/12933_2024_2319_Figa_HTML.png)
If youre already on a GLP-1, we can also support and optimize your existing prescription
![glp 1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Can GLP-1 agonists treat cardiovascular](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ad0/10739421/c03f3414f8b7/fcdhc-04-1293926-g001.jpg)
doi: 10.1016/j.foodchem.2017.08.003
![glp 1 heart disease Cardiovascular continuum-GLP-1 action. Adapted from [46] Can GLP-1 agonists treat cardiovascular](https://ars.els-cdn.com/content/image/1-s2.0-S1550413116302959-gr2.jpg)
In PD, several GLP-1RAs have demonstrated promising disease-modifying effects in phase II RCTs, and the results of phase III trials are anticipated